tailieunhanh - Aprepitant inhibits the development and metastasis of gallbladder cancer via ROS and MAPK activation

Aprepitant, as a neurokinin-1 receptor (NK-1R) antagonist, originally applied for curing chemotherapyinduced nausea and vomiting, has been reported to have significant antitumor effect on several malignant tumors. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN